Table 3. Main clinical complications during the hospitalization of patients with COVID-19.
| Sample(n = 565) | Critical(n = 225) | Non-critical(n = 340) | P-value | |
|---|---|---|---|---|
| ARDS | 98 (17.3) | 95 (42.2) | 3 (0.9) | < 0.001 |
| Nosocomial infection | 94 (16.6) | 82 (36.4) | 12 (3.5) | < 0.001 |
| Septic shock | 86 (15.2) | 82 (36.4) | 4 (1.2) | < 0.001 |
| Hyperglycemia | 88 (15.6) | 68 (30.2) | 20 (5.9) | < 0.001 |
| Pulmonary thromboembolism | 40 (7.1) | 29 (12.9) | 11 (3.2) | < 0.001 |
| Peripheral venous thrombosis | 13 (2.3) | 12 (5.3) | 1 (0.3) | < 0.001 |
| Hemorrhage | 11 (1.9) | 10 (4.4) | 1 (0.3) | < 0.001 |
Frequency (percentage); P = Pearson chi-square test; ARDS = Acute respiratory distress syndrome.